Concepedia

David Xie

DX

Statistics

Publications

4

Citations

703

H-Index

4

Active since

2001

Affiliations

Virginia Tech(Current)

David Xie is an author at Virginia Tech specializing in life sciences, pharmacology, and cancer pharmacology.

Publications per year

2001–2020

4

Publications

4

Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety

Sean K. Kelley, Louise A. Harris, David Xie et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 443 citations

Life Sciences, Oncology, Pharmacology +17

Blockchain: A new safeguard for agri-foods

Jie Xu, Shuang Guo, David Xie et al. · Artificial Intelligence in Agriculture · 2020 · 139 citations · Full text

Agriculture, Food Science, Sustainable Agriculture +17

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

Hans‐Peter Gerber, Xiumin Wu, Lanlan Yu et al. · Proceedings of the National Academy of Sciences · 2007 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages

Allison Rahtes, Kisha Pradhan, Mimosa Sarma et al. · Innate Immunity · 2019 · 14 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–4 of 4